Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Tuesday, March 6, 2012 3:03 AM | Venöse Multiple Sklerose, CVI & SVI, CCSVI Volg link
via CCSVI in Multiple Sclerosis: “The beginning of the paradigm change for MS specialists and pharma? Stanford's professor Steinman and the clinical trial of Lisinopril, an inexpensive blood pressure medication, for MS.” http://www.marketwatch.com/story/transparency-life-sciences-obtains-exclusive-option-from-stanford-university-for-use-of-lisinopril-in-multiple-sclerosis-2012-03-05


Transparency Life Sciences Obtains Exclusive Option from Stanford University for use of Lisinopril i
www.marketwatch.com